HGEN Targets GM CSF ligand not receptor - CEO made the points they this allies safe dosing over a very large range- due to added safety over Mav and other anti receptor agents. Leronlilumab May be safe but it’s Th1 CCR5 Target is far down the Cytokine chain and not as effective as Lenzilumab - which also influences Th1 plus other Targets (IL 6 TNFa etc).